Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trio-Tech International (TRT) Research & Development (2016 - 2025)

Trio-Tech International has reported Research & Development over the past 16 years, most recently at $106000.0 for Q4 2025.

  • Quarterly Research & Development fell 7.02% to $106000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $382000.0 through Dec 2025, up 1.06% year-over-year, with the annual reading at $384000.0 for FY2025, 2.04% down from the prior year.
  • Research & Development was $106000.0 for Q4 2025 at Trio-Tech International, up from $94000.0 in the prior quarter.
  • Over five years, Research & Development peaked at $151000.0 in Q4 2022 and troughed at $73000.0 in Q3 2022.
  • The 5-year median for Research & Development is $87500.0 (2023), against an average of $95350.0.
  • The largest YoY upside for Research & Development was 16.44% in 2023 against a maximum downside of 13.25% in 2023.
  • A 5-year view of Research & Development shows it stood at $131000.0 in 2021, then rose by 15.27% to $151000.0 in 2022, then dropped by 13.25% to $131000.0 in 2023, then decreased by 12.98% to $114000.0 in 2024, then fell by 7.02% to $106000.0 in 2025.
  • Per Business Quant, the three most recent readings for TRT's Research & Development are $106000.0 (Q4 2025), $94000.0 (Q3 2025), and $92000.0 (Q2 2025).